InSphero enables pharmaceutical companies to bring safer, more effective drugs to market faster using more physiologically relevant in vitro 3D models and microphysiological systems. Our scalable, assay-ready 3D InSight(TM) Microtissue and Disease Model Platforms are functionally robust, fully validated models derived from primary human or animal liver, pancreatic islet, and tumor tissue. Microtissues are delivered to your lab ready to use, removing the burden of production and validation, or are available through contract screening services conducted by our experts with 3D-optimized endpoints.
74 Orion St.
Brunswick, ME 04011